Selected immune markers are not equivalent to clinical infection resistance.
What the study found
A small partial-hepatectomy comparison measured T-cell and natural-killer-cell proportions after remimazolam or propofol anesthesia. Between-group immune-marker differences were not statistically clear, while some hemodynamic measurements differed.
The immune endpoints were cell proportions
Sixty-four patients were analyzed, with T-cell subsets, natural-killer cells and a CD4/CD8 ratio assessed after partial hepatectomy. The groups did not clearly differ in these proportions on postoperative days one and three. Those laboratory outcomes do not directly measure every immune function, surgical infection or long-term recovery. Selected hemodynamic differences in the same study answer a separate perioperative question.
Limits of interpretation
Cell percentages do not directly establish immune function, infection rates or cancer outcomes. Short follow-up and a small selected surgical sample limit inference, and nonsignificance is not proof of equivalence for every immune effect.
Implications for case review
Specify the marker and collection day before describing an immunological benefit. A favorable blood-pressure result cannot be imported into an unproven immunity claim. For an individual case, postoperative infection or recovery requires clinical evidence beyond these surrogate measurements.
Source and related reading
Source: PMC11163695, supplied full-text paper. Findings are paraphrased; forensic implications are an interpretation.
Related: Amnesia in a Small Middle-Ear Surgery Trial: Percentages and Statistical Precision.
Leave a Reply